f45 glp 1 Training Expands Partnership With Dr. B F45 Review: What the Classes

Cai et al., JAMA Ophthalmol 2025

Having daily or weekly injections of GLP-1 agonists such as Ozempic and Wegovy may become a thing of the past for people with diabetes if a new drug delivery system proves effective in humans.

Background Some observational studies found that there is an epidemiological association between type 2 diabetes (T2D) and sleep apnea (SA) and glucose-lowering drugs may lower SA risk

Berberine (BBR) exhibits significant anti-diabetic effects by enhancing insulin sensitivity, promoting glycolysis, and inhibiting gluconeogenesis

GLP-1 agents have reshaped the management of obesity, and the market continues to accelerate as new agents and indications emerge